email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
541 - 555
of 3615 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Duality Licenses ADC Platform to Adcendo for Mesenchymal Cancer Program
$5.00
Available
WuXi Biologics Signs $1.5 Billion Pact with GSK for Four Novel TCE Antibodies
$5.00
Available
HighTide Closes $107 Million Round for Metabolic/Digestive Disease Candidates
$5.00
Available
ArriVent in Hunt for $145 Million to Finance US In-licensing Operations
$5.00
Available
Transcenta Approved to Start China Trials of Gremlin1 mAb for Prostate Cancer
$5.00
Available
Biocytogen Out-Licenses Global Rights for mAb Candidates to Hansoh
$5.00
Available
ProfoundBio Starts US Trial of ADC in Solid Tumor Cancers
$5.00
Available
Boan Stages $20 Million Hong Kong IPO for Biosimilar/Novel mAb Drugs
$5.00
Available
InnoCare Approved to Launch Cytolytic CD-19 Immunotherapy in Hong Kong
$5.00
Available
Ablaze Pharma Forms CDMO Partnership with Yonghe for Radiopharmaceuticals
$5.00
Available
Junshi Out-licenses Middle East/North African Rights for PD-1 to Hikma Pharma
$5.00
Available
WuXi XDC to Offer GeneQuantum’s Platforms for Bioconjugate Development
$5.00
Available
MindRank OK’d to Start US Trials of GLP-1 Candidate for Obesity and Diabetes
$5.00
Available
TenNor Raises $10 Million for Conjugate Infectious Disease Products
$5.00
Available
IASO Approved to Start US Trials of Lead Drug, a BCMA CAR-T
$5.00
Available